Why Hospital Infusion Is Costing Your Plan Twice What It Should

For decades, hospital-based infusion therapy has been the path of least resistance. A physician orders treatment, the patient heads to the hospital infusion center, and the bill lands on the plan sponsor’s desk weeks later, often with little warning and even less context. It works, in the narrow sense that patients receive care. But for self-funded employers and plan sponsors trying to manage an increasingly strained pharmacy budget, “it works” is no longer a sufficient standard.

The uncomfortable reality is that hospital-based infusion is one of the most expensive delivery settings available, frequently costing twice as much as the identical treatment administered in an alternative care environment. This pricing gap is a structural problem for self funded plan sponsors that demand a strategic response.

The Default Setting Problem

How did hospital infusion become the default? In part, because it’s easy. Hospitals have established relationships with prescribers, they manage scheduling, and they carry the clinical infrastructure to handle complex therapies. For patients and physicians, the path is well-worn and familiar, but familiar isn’t optimal, and plan sponsors who lack visibility into where and why infusion services are being administered have largely absorbed inflated costs without question. That is beginning to change, and the savings available to plans willing to take a more active role are substantial.

What Proactive Infusion Management Actually Looks Like

The shift from passive payer to active manager starts with recognizing that infusion therapy is a clinical and logistical process that can be optimized at multiple points. The most effective programs intervene early, beginning with robust front-end prior authorization. Rather than reviewing claims after care has already been delivered, proactive authorization ensures that each therapy is clinically appropriate, correctly dosed, and directed to the most cost-effective care setting before a single infusion bag is prepared. Plans that take this approach are seeing significant savings.

From there, the work involves coordinating across a network of providers, including home infusion services and ambulatory infusion centers, to match each patient’s clinical profile with the right site of care. A patient receiving a stable, well-tolerated biologic therapy is often an excellent candidate for home infusion or an ambulatory center, with no meaningful compromise to clinical outcomes and significant reductions in cost.

The Role of Clinical Expertise and Technology

Infusion therapies span more than 300 medications, covering conditions ranging from autoimmune disorders to rare diseases to cancer supportive care. Managing them effectively demands pharmacists and clinicians who understand the full arc of each patient’s treatment: the diagnostic tests that informed the prescription, the required prior steps, the dosing parameters tied to weight and body surface area, and the monitoring markers that indicate whether therapy is working.

Technology becomes a genuine force multiplier in this context. Real-time data insights allow clinical teams to track adherence, flag deviations from expected patterns, and identify patients at risk before a crisis occurs. Customized care plans, built around each patient’s diagnosis, lifestyle, and treatment history, further improve adherence and keep patients on therapy longer and more consistently.

From Cost Center to Strategic Asset

Plans that implement comprehensive infusion oversight programs are seeing average savings of up to 50% compared to traditional models, reflecting not just site-of-care shifts but the cumulative effect of dosing accuracy, waste reduction, and avoided complications. For a self-funded employer with even a handful of members on high-cost infusion therapies, those savings can meaningfully change the trajectory of annual benefit costs.

For a deeper look at how site-of-care decisions drive these outcomes, see Rethinking Infusion Strategy: How Site of Care Drives Medical Cost Control.

Beyond the dollars, patients receiving infusion therapy through coordinated programs consistently report better experiences than those navigating the hospital system on their own. Cost containment and care quality are not in conflict here. Done well, infusion management delivers both.

Better Care, Lower Costs

Proactive infusion management, anchored in clinical expertise, supported by robust provider networks, and powered by real-time data, represents one of the clearest paths from pharmacy overspend to strategic savings available in the current benefits landscape. The plans that move first will be best positioned to protect their members and their budgets as infusion therapy costs continue to climb.

Contact us to learn how ELMCRx supports our partners in lowering this significant cost driver with innovative, proactive infusion management solutions.